Skip to main content
Top
Published in: Cardiovascular Ultrasound 1/2013

Open Access 01-04-2013 | Review

The true cost of cardiovascular imaging: focusing on downstream, indirect, and environmental costs

Authors: Larissa Braga, Bruna Vinci, Carlo G Leo, Eugenio Picano

Published in: Cardiovascular Ultrasound | Issue 1/2013

Login to get access

Abstract

To develop a more realistic assessment of costs, herein named “true” costs, the extra-cancer from medical radiation, environmental damage from imaging paraphernalia and radioactive wastes must be included as long-term costs from imaging examinations. It is urgent to define the “true” costs across imaging modalities as it interferes on physicians’ decision to request an exam and on research projects such as cost-effectiveness analysis. Cardiology is the specialty that most will benefit from the outcome as cardiovascular exams represent almost 30% of the total exams acquired annually worldwide.
Appendix
Available only for authorised users
Literature
1.
go back to reference Iglehart JK: The new era of medical imaging–progress and pitfalls. N Engl J Med. 2006, 354: 2822-8. 10.1056/NEJMhpr061219CrossRefPubMed Iglehart JK: The new era of medical imaging–progress and pitfalls. N Engl J Med. 2006, 354: 2822-8. 10.1056/NEJMhpr061219CrossRefPubMed
2.
go back to reference Smith-Bindman R, Miglioretti DL, Larson EB: Rising use of diagnostic medical imaging in a large integrated health system. Health Aff. 2008, 27: 1491-1502. 10.1377/hlthaff.27.6.1491.CrossRef Smith-Bindman R, Miglioretti DL, Larson EB: Rising use of diagnostic medical imaging in a large integrated health system. Health Aff. 2008, 27: 1491-1502. 10.1377/hlthaff.27.6.1491.CrossRef
3.
go back to reference Lehnert BE, Bree RL: Analysis of appropriateness of outpatient CT and MRI referred from primary care clinics at an academic medical center: how critical is the need for improved decision support?. J Am Coll Radiol. 2010, 7: 192-197. 10.1016/j.jacr.2009.11.010CrossRefPubMed Lehnert BE, Bree RL: Analysis of appropriateness of outpatient CT and MRI referred from primary care clinics at an academic medical center: how critical is the need for improved decision support?. J Am Coll Radiol. 2010, 7: 192-197. 10.1016/j.jacr.2009.11.010CrossRefPubMed
4.
go back to reference Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE, van Rossum AC, Shaw LJ, Yucel EK, Society for Cardiovascular Magnetic Resonance; Working Group on Cardiovascular Magnetic Resonance of the European Society of Cardiology, 2004. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J. 2004, 25: 1940-65. 10.1016/j.ehj.2004.06.040CrossRefPubMed Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE, van Rossum AC, Shaw LJ, Yucel EK, Society for Cardiovascular Magnetic Resonance; Working Group on Cardiovascular Magnetic Resonance of the European Society of Cardiology, 2004. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J. 2004, 25: 1940-65. 10.1016/j.ehj.2004.06.040CrossRefPubMed
6.
go back to reference Marwick TH, Buonocore J: Environmental impact of cardiac imaging tests for the diagnosis of coronary artery disease. Heart. 2011, 97: 1128-31. 10.1136/hrt.2011.227884CrossRefPubMed Marwick TH, Buonocore J: Environmental impact of cardiac imaging tests for the diagnosis of coronary artery disease. Heart. 2011, 97: 1128-31. 10.1136/hrt.2011.227884CrossRefPubMed
9.
go back to reference Picano E: Informed consent and communication of risk from radiological and nuclear medicine examinations: how to escape from a communication inferno. BMJ. 2004, 329: 849-51. 10.1136/bmj.329.7470.849CrossRefPubMedPubMedCentral Picano E: Informed consent and communication of risk from radiological and nuclear medicine examinations: how to escape from a communication inferno. BMJ. 2004, 329: 849-51. 10.1136/bmj.329.7470.849CrossRefPubMedPubMedCentral
11.
go back to reference Berrington De González A, Darby S: Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries. Lancet. 2004, 363: 345-51. 10.1016/S0140-6736(04)15433-0CrossRefPubMed Berrington De González A, Darby S: Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries. Lancet. 2004, 363: 345-51. 10.1016/S0140-6736(04)15433-0CrossRefPubMed
13.
go back to reference Berrington De González A, Mahesh M, Kim KP, Bhargavan M, Lewis R, Mettler F, Land C: Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med. 2009, 169: 2071-7. 10.1001/archinternmed.2009.440CrossRefPubMed Berrington De González A, Mahesh M, Kim KP, Bhargavan M, Lewis R, Mettler F, Land C: Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med. 2009, 169: 2071-7. 10.1001/archinternmed.2009.440CrossRefPubMed
14.
go back to reference Berrington de Gonzalez A, Kim KP, Smith-Bindman R, McAreavey D: Myocardial perfusion scans: projected population cancer risks from current levels of use in the United States. Circulation. 2010, 122: 2403-1. 10.1161/CIRCULATIONAHA.110.941625CrossRefPubMed Berrington de Gonzalez A, Kim KP, Smith-Bindman R, McAreavey D: Myocardial perfusion scans: projected population cancer risks from current levels of use in the United States. Circulation. 2010, 122: 2403-1. 10.1161/CIRCULATIONAHA.110.941625CrossRefPubMed
16.
go back to reference International Atomic Energy Agency, 2003. Predisposal Management of Radioactive Waste. Including Decommissioning. Safety Standards Series No. WS-R-2. 2003, Vienna: IAEA, International Atomic Energy Agency, 2003. Predisposal Management of Radioactive Waste. Including Decommissioning. Safety Standards Series No. WS-R-2. 2003, Vienna: IAEA,
18.
go back to reference Leo CG, Carpeggiani C, Picano E: Cost and benefit in cardiovascular imaging: the quest for economic sustainability. Int J Cardiovasc Imaging. 2010, 26: 613-6. 10.1007/s10554-010-9633-0CrossRefPubMed Leo CG, Carpeggiani C, Picano E: Cost and benefit in cardiovascular imaging: the quest for economic sustainability. Int J Cardiovasc Imaging. 2010, 26: 613-6. 10.1007/s10554-010-9633-0CrossRefPubMed
19.
go back to reference Levin DC, Intenzo CM, Rao VM, Frangos AJ, Parker L, Sunshine JH: Comparison of recent utilization trends in radionuclide myocardial perfusion imaging among radiologists and cardiologists. J Am Coll Radiol. 2005, 2: 821-4. 10.1016/j.jacr.2005.02.003CrossRefPubMed Levin DC, Intenzo CM, Rao VM, Frangos AJ, Parker L, Sunshine JH: Comparison of recent utilization trends in radionuclide myocardial perfusion imaging among radiologists and cardiologists. J Am Coll Radiol. 2005, 2: 821-4. 10.1016/j.jacr.2005.02.003CrossRefPubMed
Metadata
Title
The true cost of cardiovascular imaging: focusing on downstream, indirect, and environmental costs
Authors
Larissa Braga
Bruna Vinci
Carlo G Leo
Eugenio Picano
Publication date
01-04-2013
Publisher
BioMed Central
Published in
Cardiovascular Ultrasound / Issue 1/2013
Electronic ISSN: 1476-7120
DOI
https://doi.org/10.1186/1476-7120-11-10

Other articles of this Issue 1/2013

Cardiovascular Ultrasound 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.